Earnings Call · Q3 FY2024·2024-11-15

Q3 24EPS -7.69%·Rev n/aQ2 24EPS +13.51%·Rev n/aQ1 24EPS +6.98%·Rev n/aQ4 23EPS 0.00%·Rev n/a⚠ consensus missing

VOLITIONRX LTD VNRX

Louise Batchelor — Role not explicitly stated, likely investor relations or communications

Tom Butera — Role not explicitly stated, likely senior executive or investor relations

Andrew Retter — Chief Medical Officer

Terig Hughes — Chief Financial Officer

Cameron Reynolds — Chief Executive Officer

−5.6%1d on move date−4.3% vs SPY3d−6.9%5d+12.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VNRX calls or request research access.

More VNRX calls Browse calls Request research access